Lipid-poor adrenal masses raise concerns about the underlying pathology. Herein we present a case of a patient with a lipid-poor adrenal mass that proved to be a rare adrenal leiomyosarcoma.
The patient was a 72-year-old man who was incidentally discovered to have a 2-cm left adrenal mass on an abdominal computed tomography (CT) scan that was obtained to evaluate abdominal pain ( Fig. 76.1 ). His physician advised follow-up CT scan 6 months later. However, the follow-upabdominal CT scan was not performed until1.5 years later, when the left adrenal mass measured 5.1 × 3.2 × 5.1 cm with an unenhanced CT attenuation of 32.3 Hounsfield units (HU) (see Fig. 76.1 ). He had no paroxysmal symptoms. He did have a 30-year history of hypertension, which was controlled with a four-drug program. Type 2 diabetes mellitus had been diagnosed 6 years previously. His weight had been stable. He had no signs or symptoms of Cushing syndrome. There was no history of hypokalemia. His medications included amlodipine, 10 mg daily; lisinopril, 20 mg daily; metoprolol, 50 mg daily; hydrochlorothiazide, 12.5 mgdaily; and metformin, 850 mg twice daily. On physical examination his body mass index was41.8 kg/m 2 , blood pressure 125/72 mmHg, and heart rate 69 beats per minute. He had no stigmata of an adrenal disorder. Heart and lung examinations were normal.
The laboratory studies were normal ( Table 76.1 ). There was no biochemical evidence of functioning pheochromocytoma, cortisol secretory autonomy, or primary aldosteronism. A F-18 fluorodeoxyglucose (FDG) positron emission tomography scan showed a FDG-avid left adrenal mass and no other areas of abnormal uptake ( Fig. 76.2 ).
|Biochemical Test||Result||Reference Range|
|Sodium, mmol/L |
Fasting plasma glucose, mg/dL
Plasma renin activity ng/mL per hour
1-mg overnight DST, cortisol mcg/dL
Plasma metanephrine, nmol/L
Plasma normetanephrine, nmol/L